Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Viruses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02438917
What this trial is testing

Biomarkers of Liver Fibrosis

Who this might be right for
Hepatitis C
Icahn School of Medicine at Mount Sinai 10
Early research (Phase 1)Study completedNCT01018615
What this trial is testing

Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis COxidative Stress
University of North Carolina, Chapel Hill 28
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07071636
What this trial is testing

Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseChronic Hepatitis B
Shenzhen Third People's Hospital 830
Not applicableStudy completedNCT01474811
What this trial is testing

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 13,559
Not applicableUnknownNCT05614466
What this trial is testing

The SIMPLY-B Study

Who this might be right for
Hepatitis B Virus Related Hepatocellular Carcinoma
Nadine Barnes 100
Not applicableStudy completedNCT02355951
What this trial is testing

Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

Who this might be right for
Chronic Hepatitis B
Transgene 166
Large-scale testing (Phase 3)Study completedNCT01290731
What this trial is testing

TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 49
Large-scale testing (Phase 3)Study completedNCT02032901
What this trial is testing

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 173
Testing effectiveness (Phase 2)Study completedNCT02138253
What this trial is testing

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

Who this might be right for
Liver FibrosisHepatic FibrosisLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 64
Early research (Phase 1)Study completedNCT01288677
What this trial is testing

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Tibotec Pharmaceuticals, Ireland 54
Not applicableStudy completedNCT05018741
What this trial is testing

Prognostic Factors After Liver Transplantation

Who this might be right for
Liver DiseasesLiver Transplant; Complications
Changhua Christian Hospital 600
Testing effectiveness (Phase 2)Study completedNCT01777295
What this trial is testing

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Who this might be right for
Hepatitis B
GlaxoSmithKline 81
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Large-scale testing (Phase 3)Ended earlyNCT01694264
What this trial is testing

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Who this might be right for
Chronic Hepatitis BRheumatoid ArthritisAnkylosing Spondylitis+2 more
Seoul National University Hospital 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06993480
What this trial is testing

Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 20
Post-approval studies (Phase 4)Study completedNCT00169858
What this trial is testing

Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

Who this might be right for
Hepatitis BVaccination
Laval University 1,129
Testing effectiveness (Phase 2)Study completedNCT01548690
What this trial is testing

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Who this might be right for
Acute Liver FailureAcute Liver Injury
William Lee 47
Early research (Phase 1)Study completedNCT01063023
What this trial is testing

Drug Interaction Oral Contraceptive Pill (OCP)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 20
Testing effectiveness (Phase 2)Study completedNCT01326546
What this trial is testing

Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 378
Next Page